SENSEX NIFTY
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Venkat Pharma - BSE: 532093, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Venkat Pharma
Venkat Pharma
BSE: 532093|ISIN: INE346F01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 30, 17:00
3.27
-0.17 (-4.94%)
VOLUME 1,400
Venkat Pharma is not listed on NSE
« Mar 11
Notes to Accounts Year End : Mar '13
1.1 Estimated amount of contracts remaining to be executed on capital
 account and not provided for (net of advance) Rs. NIL(Previous year Rs.
 NIL).
 
 1.2. A) CONTINGENT LIABILITIES:
 
 There is demand of Rs.9,91,91,785/- from Commercial Tax Department &
 Rs. 47,14,039/- from Income Tax Department for which no provision has
 been made as the company has preferred an appeal.
 
 B) Claims against the company not acknowledge as debts Rs.-Nil-
 Previous year Rs.Nil.
 
 1.3. Secured Loans:
 
 The Cash Credit loans from banks are secured by a charge created
 through an equitable mortgage of immovable properties by deposit of
 title deeds and hypothecation of stock in trade, book-debts and stores
 & spares, present and future.
 
 The Previous year loan outstanding taken as same in this year due to no
 banking transactions in this year.
 
 1.4. Supdry Debtors, Loans and Advances:
 
 In the opinion of the Management, the value on realization of Current
 Assets, Loans and advances and other debit balances in the ordinary
 course of business will not be less than the amount at which they are
 stated in the Balance Sheet.
 
 Pending comprehensive review of balances under Loans and Advances,
 considered good by the management, no provision has been considered
 towards short fall in recovery in the accounts.
 
 Balances under Sundry Debtors and Loans and Advances are subject to
 confirmation from respective parties.
 
 1.5. Deferred Taxation:
 
 No provision for deferred taxation was made, because of huge loss
 suffered by the company.
 
 1.6.  MANAGERIAL REMUNERATION:
 
 Remunerations not paid during the year.
 
 1.7.  Retirement benefits/ estimated liability for Gratuity/leave
 encashment on the Balance Sheet date has not been quantified. The same
 will be accounted on actual payment basis.
 
 1.8.  All Sundry Creditors and Debtors are being opening balances, SSC
 classification does not apply.
 
 1.9.  Pending finalization of the proposal regarding rescheduling of
 the loan by our bankers no interest provision has been made.
 
 1.10 The information as required by Para 3 & 4 of part II of the
 schedule VI to the Companies Act, 1956 is as under.
 
 1.11 Previous Year figures have been regrouped / reclassified /recast
 wherever necessary to confirm with current year''s classifications.
 
 1.12 The figures have been rounded off to the nearest rupee.
 
 1.13 There are no related party transactions during the years.
 
 1.14 Earning pershare
 
 A) The stock records of the company are under the custody of a
 statutory authority for certain verification and hence quantitative
 details could not be compiled.
 
 1.15 Pending detailed technical valuation of stock on hand no provision
 for obsolesce has been made during the year.
Source : Dion Global Solutions Limited
Quick Links for venkatpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.